Breast Cancer Screening: Women Over 70 Debate

Full Debate: Read Full Debate

Baroness Nargund

Main Page: Baroness Nargund (Labour - Life peer)

Breast Cancer Screening: Women Over 70

Baroness Nargund Excerpts
Tuesday 2nd June 2026

(1 month, 3 weeks ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate
Baroness Blake of Leeds Portrait Baroness Blake of Leeds
- View Speech - Hansard - - - Excerpts

I declare an interest, in that I am in the same age group. All I can say from personal experience is that, when I went for my last screening, I was informed by the local screening team. This speaks to the point that it is patchy and inconsistent; we need to have a fundamental check around the country to ensure that consistency exists. The noble Baroness has made my point perfectly: too many women are not aware of what is available. That is why we are going to address the needs of women going forward.

Baroness Nargund Portrait Baroness Nargund (Lab)
- View Speech - Hansard - -

My Lords, I thank the noble Lord, Lord Palmer, for raising this and my noble friend the Minister for raising awareness about one of the largest age-extension trials. It is true that it will give us results, but I was not aware that the final report would be available in 2027; I was under the impression that it would be by 2032. Can my noble friend confirm that the final report on age extension will be available by 2027? In the meantime, given that international professional guidelines support regular screening for women over 70, could we consider regular screening for women in the community when we establish neighbourhood health centres?

Baroness Blake of Leeds Portrait Baroness Blake of Leeds
- View Speech - Hansard - - - Excerpts

I stress the importance of being mindful of all ongoing research, as there is extensive research going on in all areas of cancer. We also need to be very mindful of the new technologies coming forward. The EDITH programme, looking at the use of AI, could potentially significantly reduce the number of medical practitioners who need to be involved in screening, thus freeing up capacity and making sure that trials can be implemented. I want to reassure my noble friend of the work that is happening and the intention to abide by the timeframes set.